Discover

BCAB
BioAtla, Inc.
4.08
2 x 3.03
2 x 5.04
bid
ask
-
0.05
1.33%
2 @ 04:00 PM
3.92 -0.17 (4.15%)
Ytd-85.62%
1y-79.10%
3.86
day range
4.28
3.12
52 week range
71.50
Open4.10Prev Close4.14Low3.86High4.28Mkt Cap6.78M
Vol58.90KAvg Vol52.84KEPS-41.56P/EN/AForward P/E-0.42
Beta1.02Short Ratio3.70Inst. Own42.79%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg4.03200-d Avg19.421yr Est9.00
Income Statement
Operating Expenses9.31M
Research and Development Expense4.58M
Selling, General and Administrative Expense4.73M
Operating Income-9.31M
Net Income-6.34M
Net Income Common Stock-6.34M
Net Income Common Stock (USD)-6.34M
Consolidated Income-6.34M
Earnings per Basic Share-4.22
Earnings per Basic Share (USD)-4.22
Earnings per Diluted Share-4.22
Earning Before Interest & Taxes (EBIT)-6.34M
Earning Before Interest & Taxes (USD)-6.34M
Weighted Average Shares1.50M
Weighted Average Shares Diluted1.50M
Balance Sheet
Cash and Equivalents1.96M
Cash and Equivalents (USD)1.96M
Current Assets3.09M
Property, Plant & Equipment Net5.31M
Total Assets8.57M
Debt Current1.56M
Total Debt6.09M
Current Liabilities20.69M
Debt Non-Current4.54M
Total Liabilities45.88M
Accumulated Retained Earnings (Deficit)-551.99M
Shareholders Equity-37.31M
Shareholders Equity (USD)-37.31M
Assets Non-Current5.47M
Total Debt (USD)6.09M
Liabilities Non-Current25.18M
Trade and Non-Trade Payables19.13M
Cash Flow
Depreciation, Amortization & Accretion120.00K
Net Cash Flow from Financing110.00K
Net Cash Flow / Change in Cash & Cash Equivalents-5.16M
Issuance (Purchase) of Equity Shares124.00K
Net Cash Flow from Operations-5.27M
Share Based Compensation956.00K